SLC5A2 and heart failure: However, medical therapy for heart failure has also evolved in recent years, specifically with the emergence of angiotensin receptor‐neprilysin inhibitors (ARNIs) and sodium‐glucose cotransporter‐2 (SGLT2) inhibitors.31